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Nijmegen, The Netherlands
Summary. Attention deﬁcit=hyperactivity disorder (ADHD) is a common and
impairing neuropsychiatric disorder with onset at preschool age and strong per-
sistence over time. Its validity as a psychiatric disorder has been established
according to Robins and Guze criteria. Genetic factors predominate in the etiol-
ogy of ADHD. This paper summarizes the current status of genetic research into
ADHD, and describes eight factors that complicate research into genetically
complex disorders as ADHD. These factors are that multiple genes of small main
effects are involved rather than main genes, the relevant phenotype is unknown,
presence of clinical heterogeneity, presence of genetic heterogeneity, gene-envi-
ronment correlation, gene-environment interaction, importance of endopheno-
types, and importance of developmental factors. The further unraveling of the
genetic architecture of ADHD will depend to a large extent on how well these
complicating factors are handled or even used.
Introduction
Attention deﬁcit=hyperactivity disorder (ADHD) is a common and impairing
neuropsychiatric disorder with onset at preschool age. It is thought to affect
3–5% of all schoolage children and is characterized by age-inappropriate symp-
toms of hyperactivity, inattentiveness and impulsivity (American Psychiatric
Association, 1994; Buitelaar, 2002). This pattern can be viewed as the extreme
of a complex trait that is continuously distributed in the general population and
shows a strong overlap with aggressive behavior. The Fourth Edition of the
Diagnostic and StatisticalManual (DSM-IV) recognizes three subtypes of ADHD,
the predominantly inattentive subtype, the predominantly hyperactive-impulsive
subtype and the combined subtype (American Psychiatric Association, 1994).
Eighty percent of the children that are diagnosed with ADHD display symptoms
in all three domains of inattentiveness, hyperactivity and impulsivity, though at
the level of the general population, the inattentive subtype of ADHD is most
prevalent (Buitelaar, 2002). There is a much higher incidence rate in boys, who
are 1.5–5.8 times more likely than girls to be diagnosed with ADHD (Buitelaar,
2002). The disorder often has a chronic course with about 70% of affect-
ed children having threshold ADHD symptoms and associated impairment in
adolescence and 30–50% of affected children displaying ADHD symptoms into
adulthood (Weiss et al., 1993; Barkley et al., 1990). The presence of comorbid
disorders is the rule rather than the exception. Common comorbidities in children
and adolescents include oppositional deﬁant disorder and conduct disorder, anx-
iety disorders, mood disorders (Biederman et al., 1991), tic disorders, motor
coordination disorder (Robinson et al., 1993), learning disabilities (Semrud-
Clikeman et al., 1992) and problems in reciprocal social interaction and com-
munication that overlap with those described in autism spectrum disorders
(Luteijn et al., 2000a, b). In adolescence and adulthood, comorbid risk taking
behaviors and substance abuse disorders are rising in prevalence (Wilens, 2004)
as well as antisocial personality disorder (Mannuzza et al., 1989) and borderline
personality disorder (Fossati et al., 2002). Numerous problems are further asso-
ciated over development with ADHD, such as poor academic performance,
school drop out, social isolation, and lower occupational success (Weiss et al.,
1993; Barkley et al., 1990).
ADHD has been ﬁrmly established as a psychiatric disorder that meets
the criteria for the validation of psychiatric diagnoses as outlined by Robins
and Guze (1970) (Faraone, 2005a). In spite of this, the disorder’s validity has
been challenged and criticized by popular media, journalists and politicians
(Buitelaar and Rothenberger, 2004). ADHD has been stated to be a result of
inadequate parenting and teaching in an overstressed society which places to
high demands on children’s self-control and self-organizational skills. Normal
developmental variation and particularly boyish energy and adventurousness
have been medicalized. Worries have been further expressed about potential
overdiagnosis and overtreatment of ADHD, and particularly on the dangers of
the treatment with psychostimulants. Unfortunately, this has led to increase
barriers for referral and block access to adequate diagnosis and treatment for
children with ADHD and their parents (Buitelaar and Rothenberger, 2004).
The aim of this communication is to summarize the current status of genetic
research into ADHD and to describe strategies to further unravel ADHD’s
genetic architecture.
Behavior-genetic studies
Twin, family, adoption and molecular genetic studies show that genes play a
very substantial role in the etiology of ADHD. Family-genetic studies indicate
that ADHD aggregates in families, with a 5–8 fold increased risk in ﬁrst-degree
relatives and a 2-fold increased risk in second-degree relatives (Faraone et al.,
1994). Twin studies found evidence for a narrow additive heritability of 0.75 to
0.91 which was robust across familial relationships and across deﬁnitions of
ADHD as the end of a continuum or as a disorder with various symptom cutoffs
(Levy et al., 1997; Sherman et al., 1997). For further review of twin studies, see
Faraone et al. (2001) and Thapar et al. (1999). Given the modest relative risk
ratios in siblings and the fall-off in risk from ﬁrst to second-degree relatives, the
high heritability of ADHD is likely to be due to multiple genes of small effect
size (called quantitative trait loci, QTLs, or susceptibility genes) rather than a
few genes of major effect. The latter result of the twin studies further indicates
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that a QTL approach to the study of the genetics of ADHD is valid and that
genes associated with a complex trait measure of ADHD very likely will also
show to be relevant for ADHD deﬁned as a categorical psychiatric disorder, and
vice versa. The fact that heritability is less than 1.0 shows further that features
of the environment are also involved in the etiology of the disorder.
Adoption studies of ADHD also implicate genes in its etiology. The adop-
tive relatives of ADHD children are less likely to have ADHD or associated
disorders than are the biological relatives of ADHD children (Morrison et al.,
1973; Cantwell, 1975). Biological relatives of ADHD children also do more
poorly on standardized measures of attention than do adoptive relatives of
ADHD children (Alberts-Corush et al., 1986).
Genome scans
To date, there have been performed three independent genome scans of ADHD.
Table 1 summarizes their main results. A ﬁrst genomewide scan for loci in-
volved in ADHD in 126 affected sib pairs pointed to a number of chromosomal
sites that may contain risk factors of moderate effect (Fisher et al., 2002). None
of these exceeded genomewide signiﬁcance thresholds, with LOD scores >1.5
(but<1.66) on 5p12, 10q26, 12q23 and 16p13. The regions containing 29 out of
36 candidate genes, including DRD4 and DAT1, could be excluded for a l of 2.
An extension study in a larger sample of 227 ASPs that focused on chromo-
some 16q13 was able to establish linkage (LOD score 4.2) (Smalley et al.,
2002). A further follow-up investigation extended the original sample of 126
Table 1. Summary of regions implicated in genome scans of ADHD and
overlap with regions implicated in other disorders
Study Region LOD Implicated in
autism4
Implicated in
dyslexia5
UCLA1 5p13 2.6 X
UCLA1 6q12 3.3
UCLA1 16p13 3.7 X
UCLA1 17p11# 3.6 X
Netherlands2 15q15 3.5 X X
Netherlands2 7p13 3.0
Netherlands2 9q33 2.1
Columbia3 17p11# 2.8 X
Columbia3 11q22 2.5
Columbia3 5q33.3 2.4
1UCLA study of 270 sib-pairs (Fisher et al., 2002; Smalley et al., 2002;
Ogdie et al., 2003, 2004)
2Dutch study of 164 sib-pairr (Bakker et al., 2003)
3Columbian study of 14 three-generation pedigrees (Arcos-Burgos et al.,
2004)
4For review of genome scans in autism, see Muhle et al. (2004)
5For review of genome scans in dyslexia, see Demonet et al. (2004)
#Replication of same region
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ASPs to 270 ASPs and provided linkage analyses of the entire sample (Ogdie
et al., 2003). Maximum LOD score (MLS) analysis identiﬁed suggestive link-
age for 17p11 and four nominal regions with MLS values 11.0, including 5p13,
6q14, 11q25, MLS p 2.98 and 20q13. These data, taken together with the ﬁne
mapping on 16p13, suggested two regions as highly likely to harbor risk genes
for ADHD: 16p13 and 17p11. Next, ﬁne mapping was completed of nine posi-
tional candidate regions for ADHD in an extended population sample of 308
ASPs (Ogdie et al., 2003). The candidate chromosomal regions were selected
from all three published genomewide scans for ADHD, and ﬁne mapping was
done to comprehensively validate these positional candidate regions in our
sample. Multipoint maximum LOD score (MLS) analysis yielded signiﬁcant
evidence of linkage on 6q12 (MLS 3.30) and 17p11 (MLS 3.63), as well as
suggestive evidence on 5p13 (MLS 2.55).
A second genome scan was performed on 164 Dutch affected sib pairs (ASPs)
with ADHD (Bakker et al., 2003). Initially, a narrow phenotype was deﬁned, in
which all the sib pairs met the full ADHD criteria (117 ASPs). In a broad pheno-
type, additional sib pairs were included, in which one child had an autistic-spec-
trum disorder but also met the full ADHD criteria (164 ASPs). This genome scan
indicated several regions of interest, two of which showed suggestive evidence for
linkage. The most promising chromosome region was located at 15q, with an
MLS of 3.54 under the broad phenotype deﬁnition. This region was previously
implicated in reading disability and autism. In addition, MLSs of 3.04 and 2.05
were found for chromosome regions 7p and 9q in the narrow phenotype. Except
for a region on chromosome 5, no overlap was found with regions mentioned in
the only other independent genome scan in ADHD reported to date.
The third genome scan was performed in 14 three-generation pedigrees with
ADHD from a genetic isolate (Arcos-Burgos et al., 2004). In these families,
ADHD is highly comorbid with conduct and oppositional deﬁant disorders, as
well as with alcohol and tobacco dependence. Evidence was found of linkage
to markers at chromosomes 4q13.2, 5q33.3, 8q11.23, 11q22, and 17p11 in
individual families. Fine mapping applied to these regions resulted in signiﬁ-
cant linkage in the combined families at chromosomes 4q13, 5q33.3, 11q22 and
17p11. Additionally, suggestive linkage was found at chromosome 8q11.23.
Several of these regions were novel (4q13.2, 5q33.3, and 8q11.23), whereas
others replicated already-published loci (11q22 and 17p11).
The lack of replication across the studies completed so far adds to the earlier
conclusion that genes of moderately large effect are unlikely to exist, and for this
reason, further studies are needed to increase the power of available linkage data.
Another important outcome of the genome scans is that there appears to be
considerable overlap in regions of the genome that are implicated in ADHD,
and those that are implicated in other conditions as autism and dyslexia (Table 1).
Candidate gene studies
Numerous candidate genes have been studied for their possible association
with ADHD. For more extensive review, see Faraone et al. (2005b). These
candidate genes have been chosen to be relevant for current neurobiologi-
cal theories of ADHD. Many groups have examined associations between
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ADHD and genes involved in dopaminergic neurotransmission, mainly because
psychostimulants, among the most effective drugs used to treat ADHD, partly
block the dopamine transporter (DAT1) function (Volkow et al., 2001;
Buitelaar et al., 1995). Dopamine acts also as a agonist at dopaminergic recep-
tor systems. Most studies of the dopamine transporter (DAT1-SLC6A3) gene
in ADHD have examined a 10 repeat sequence in the 30 untranslated region.
When family-based studies of this polymorphism were pooled, the odds ratio
is small but signiﬁcant (1.13, 95% CI 1.03–1.24), suggesting that SLC6A3
merits further investigation but that its effect is modest. One of the best stud-
ied candidate genes is the Dopamine D4 receptor (DRD4). Researchers have
predominantly focused on a tandem repeat polymorphism in exon III of DRD4
because in vitro studies have shown that one variant (the 7-repeat allele)
produces a blunted response to dopamine (Asghari et al., 1995; Van Tol et al.,
1992). Despite some variation across studies, when data from analyses of the
exon III polymorphism are pooled, the association with ADHD remains sta-
tistically signiﬁcant (case-control odds ratio¼ 1.45 (95% CI 1.27–1.65);
family based OR¼ 1.16 (95% CI 1.03–1.31). Although the functional impli-
cations of mutations in DRD5 are not well understood, there is some evi-
dence for association with long-term potentiation in corticostriatal regions
and with locomotion and prepulse inhibition (Manor et al., 2004). A recent
analysis that combined 14 independent samples from family-based studies
(Lowe et al., 2004) identiﬁed a signiﬁcant association of the 148 bp allele
with ADHD, (OR¼ 1.2; 95% CI 1.1–1.4). Dopamine Beta-Hydroxylase
(DBH) is the primary enzyme responsible for conversion of dopamine to nor-
epinephrine. When family-based studies of this gene are pooled, they jointly
suggest a signiﬁcant association between ADHD and the 50 Taq1 polymor-
phism (OR¼ 1.33, 95% CI 1.11–1.59).
The norepinephrine transporter (SLC6A2) has been examined in ADHD
because drugs that block the norepinephrine transporter are efﬁcacious in treating
ADHD (Banaschewski et al., 2004). No evidence of association was found for
these loci or the haplotypes comprising them in a study that examined SNPs in
exon 9, intron 9 and intron 13 in 122 ADHD families and found (Barr et al.,
2002). No association with intron 7 and intron 9 SNPs was seen in a study of
Irish families (McEvoy et al., 2002), or with a restriction fragment length poly-
morphism in offspring of adults with ADHD (De Luca et al., 2004).
Serotonin transporter (SLC6A4) is perhaps the best-studied gene in psychiat-
ric genetics, with associations reported for a broad range of diagnoses and traits
(Anguelova et al., 2003a, b). When the studies of the ‘long’ allele of HTTLPR
are combined, the pooled odds ratio for the long allele in ADHD samples is
1.31 (95% CI 1.09–1.59). Two family-based association studies examined a
silent SNP (G861C) in the gene coding for the serotonin HTR1B receptor. In
predominantly Caucasian samples, both studies found over-transmission of the
‘‘G’’ allele, though this ﬁnding only reached statistical signiﬁcance in the very
large study which reported pooled results from four sites (Hawi et al., 2002).
The association between the over-transmission of the ‘‘G’’ allele and ADHD
reached signiﬁcance as well in a study that analyzed paternal transmission
(Quist et al., 2003). The pooled odds ratio for the G861C SNP is 1.44 (95%
CI 1.14–1.83).
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While these ﬁndings on candidate genes are interesting, it is important to
note that these genes are of low effect size and explain only approximately 2%
of the variance in symptomatology. Further, most of these studies are based on
just one of possibly many functional polymorphic variations in speciﬁc genes
of interest and, unfortunately, most results are inconsistent.
Environmental inﬂuences
Before turning to a discussion of the complicating factors in genetic studies, rele-
vant environmental inﬂuences will be summarized. Several environmental risks
for ADHDhave been identiﬁed and these are all good candidates formoderation of
genetic inﬂuences. These environmental risks can be grouped into three cate-
gories: 1) pre- and perinatal inﬂuences, such as prematurity, low birth weight,
pregnancy and birth complications (Hille et al., 2001; Botting et al., 1997; Mick
et al., 2002a, b), and mother’s use of alcohol or tobacco during pregnancy
(Milberger et al., 1996); 2) parental and family factors such as critical expressed
emotion versus expressed warmth, inconsistent parenting, parental divorce, family
conﬂict and early institutional rearing (Rutter et al., 2001;Woodward et al., 1998);
and 3) acquired neurobiological risks such as closed head trauma and exposure to
lead (Thomson et al., 1989; Max et al., 2004; Schachar et al., 2004).
Concerning obstetric adversity, a birth weight lower than 2500 g raises the
risk to ADHD about 3–10 times (Breslau et al., 1996; Whitaker et al., 1997). A
recent twin study could replicate the association between lower birth weight
and increased levels of behavior problems in children as an independent main
effect. Interestingly, and in addition, there was an interaction between birth
weight and genetic factors in that lower birth weight was associated with
decreased genetic inﬂuence (Van Os et al., 2001). Obstetric adversity may be
co-dependent of the characteristics of the fetus and may mediate genetic risks,
as has been shown in the case of autism (Glasson et al., 2004; Bolton et al.,
1997). For example, non-affected siblings were more similar to their affected
probands than to controls in their proﬁle of birth complications (Glasson et al.,
2004). Studies among clinically referred children report particularly high rates
of toxemia or eclampsia, maternal illness, maternal psychological stress, bleed-
ing, lengthy labor or delivery, and undue weight loss or gain of the pregnant
mother for children with ADHD compared to control children (Milberger et al.,
1997; Sprich-Buckminster et al., 1993).
Concerning family functioning, children with ADHD live in a family-
environment characterized by marital discord, high rates of parental psychiatric
disorder, and low occupation status much more often than controls (Scahill
et al., 1999). Family adversity factors as marital discord, low SES, large family
size, paternal criminality, maternal mental disorder, and foster placement in-
creased the risk for ADHD and predicted for comorbid disorders, cognitive
impairment, and psychosocial dysfunction (Biederman et al., 1995). It is impor-
tant to appreciate that these associations between family-environment and
ADHD are difﬁcult to interprete since a number of these factors such as par-
ental disorder may both reﬂect genetic transmission and exert an adverse inﬂu-
ence through the alteration of parent-child relationships. Further, the family
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adversities may well be, in part, the consequence of having a problematic child
with ADHD rather than the cause of it. Finally, these associations between
factors that are deﬁned at the level of the family as a whole, are hard to recon-
cile with the importance of the nonshared rather than the shared environment,
as is shown by twin studies. For example, in an Australian twin study, non-
shared environmental inﬂuences accounted for about 15% of the variance of
ADHD symptoms (Rhee et al., 1999).
Therefore, we will review now work on disrupted parent-child relationships
and hyperactivity=aggression. Careful characterization of parent-child relation-
ships of hyperactive children derived from community studies points to the impor-
tance of abnormalities of affective tone (especially hostile expressed emotion,
HEE) and impairment of parental coping skills (Taylor et al., 1991; Woodward
et al., 1998). HHE was seen in 33% of mothers of hyperactive children and in 6%
of healthy controls. Poor coping skills were seen in 44% of mothers of hyperactive
children and 15% of healthy controls (Woodward et al., 1998). These two sets of
ﬁgures give odds ratios for the two environmental factors of 7.7 and 3.8 respec-
tively. Hostile parent-child interactions were further found to predict the long-
itudinal course of children with hyperactivity (Rutter et al., 1997).
Further research is needed to determine whether these are proximal risks
effecting the brain directly (e.g. toxicity from alcohol), act indirectly (e.g.
maternal drinking correlates with poor parenting and poor parenting is proximal
risk), are genetically correlated with the genotype of the mothers (e.g. mothers
with ADHD are more prone to smoke during pregnancy than mothers without
ADHD) or are genetically correlated with the ADHD proband genotype
(e.g. ADHD behavior evokes hostile expressed emotion in the parent).
Complicating factors
Discovering genes involved in ADHD is complicated by several factors (Table 2).
The further unraveling of the genetic architecture of ADHD will depend to a
large extent on how well these complicating factors are handled and even used.
The ﬁrst one is that the identiﬁcation of genes of small main effects requires the
use of very large sample sizes (Risch et al., 1996). These can only be collected
by large consortia, and several of these have been formed over the past years,
among which the International Multi-center ADHD GEnetics Project (IMAGE)
Table 2. Complicating factors in genet-
ic studies in complex genetic disorders
like ADHD
1. Multiple genes of small main effects
2. The relevant phenotype is unknown
3. Clinical heterogeneity
4. Genetic heterogeneity
5. Gene-environment correlation
6. Gene-environment interaction
7. Importance of endophenotypes
8. Importance of developmental factors
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Consortium (Asherson, 2004). This consortium under the leadership under Steve
Faraone includes more than 10 sites in Europe and aims to collect at least 2000
ADHD families. From these, the 400 most informative concordant pairs and
the 400 most informative discordant pairs will be used for initital genomewide
linkage studies. Collaborative work has been further facilitated by the ADHD
Molecular Genetics Network (NIH grant to Steve Faraone) which comprises
investigators from around the world who currently study the genetics of ADHD
and meet on a regular basis. A second forum is the EUropean NETwork of
HYperactivity DISorders (Eunethydis) (leadership Joe Sergeant) which also
has yearly meetings to discuss potential and actual collaboration.
A second factor is that it is unknown on which phenotype molecular-genetic
studies should focus. Traditional psychiatric categories as deﬁned in classiﬁcation
schemes as DSM-IV and ICD-10 have been developed for clinical purposes but
have not been selected for being relevant phenotypes for genetic research. Twin
studies for example indicate that ADHD, and oppositional-deﬁant=conduct dis-
order share a substantial amount of genetic factors in childhood (Silberg et al.,
1996). There are several approaches to improve the deﬁnition of the relevant
phenotype for genetic studies. One is based on the work of Risch (1990a, b),
who proved that the statistical power of a linkage study increases with the magni-
tude of risk ratios computed by dividing the affection rate among each relative type
(e.g., siblings, offspring) to the rate of affection in the population. These ratio’s
have been called ‘‘lambdas.’’ It was shown that the power depends only on lambda
and that deﬁning disease status in a manner that increased lambda would increase
the power of linkage studies. According to this logic, Faraone et al. (2000) demon-
strated that lambdas were greater if the ADHD proband also has conduct disorder
(4.5 and 8.6) and were even greater if the proband has persistent ADHD (17.2 and
19.5). The highest lambdas were found when the proband had both persistent
ADHD and CD (25.0–25.9). Another strategy is to fully exploit the potential of
twin studies to separate genetic from environmental inﬂuences. Though aggregate
constructs of ADHD were shown to have heritability as high as 0.80 (see above),
similar heritability estimates would not necessarily apply to the single items that
are included in these constructs. Twin analyses on single items could afford further
information on the decomposition of genetic and environmental inﬂuences at the
item level, and result in the construction of more ‘‘pure’’ genetically relevant
phenotypes. This strategy has been underused sofar. A third strategy is the use
of newer multivariate techniques as latent class analysis on ADHD symptoms in
twin designs. Such a latent class analysis was applied to data obtained from parents
on the 18 DSM-IVADHD symptoms in 4,036 female twins age 13–23 years in a
population sample in Missouri (Todd et al., 2001). The latent-class analysis was
most compatible with the existence of three mild and three severe classes of
ADHD symptoms in the general population. Unlike DSM-IV subtypes of ADHD,
latent-class ADHD subtypes appear to be independently transmitted in families.
These classes may be more appropriate targets for molecular genetic studies of
ADHD. In another twin dataset the inclusion of sluggish cognitive tempo items
markedly changed ADHD symptom associations for boys and girls in a factor
analytic framework. In contrast, latent class subtyping of ADHD shows limited
impact of the inclusion of sluggish cognitive tempo items, emphasizing the very
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different assumptions about underlying continua of behavior rather than discrete
classes that distinguish the two approaches (Todd et al., 2004). Sofar, latent class
subtypes of ADHD have not been used in genetic linkage studies.
Linked to the previous issue of the deﬁnition of the phenotype is that of
clinical heterogeneity, i.e. that different siblings in a given family may have a
different clinical presentation. For example, one sibling may present with one of
the ADHD subtypes, whereas another sibling may have dyslexia without ADHD
and a third sibling may have autism spectrum disorder (ASD) with comorbid
ADHD. The challenges but also opportunities of clinical heterogeneity have not
been met addressed sufﬁciently, particularly in terms of the overlap between
ADHD, ASD and dyslexia. Many children with ASD suffer from inattention,
hyperactivity and impulsivity to an extent that clinical management of these
ADHD-like symptoms is warranted (Handen et al., 2000; Quintana et al., 1995).
Re-analyses of the results of population studies on deﬁcits in attention, motor
control and perception (DAMP, i.e. a combination of ADHD and perceptual-
motor problems) also revealed a strong overlap between severe DAMP and
ASD (Kadesjo et al., 1999; Gillberg, 1992). In a similar way, many children
with Attention Deﬁcit Hyperactivity Disorder (ADHD) have associated social
deﬁcits that are not part of the core symptoms of inattention, hyperactivity and
impulsivity that deﬁne the disorder. In a study of social disability in ADHD the
majority of a sample of 140 boys with ADHD had some degree of difﬁculty in
the social domain (Greene et al., 1996); 22% even qualiﬁed as socially disabled,
as compared to none of a group of 120 normal controls. In another study, the
Children’s Social Behavior Questionnaire (CSBQ) was used to compare social
deﬁcits in children with ASD, children with ADHD and normal controls (Luteijn
et al., 2000a, b). Children with ADHD were characterized by signiﬁcant social
deﬁcits in social interaction and communication and by an increase in stereotypic
and restricted behavior, in comparison with normal controls. Although these
deﬁcits were signiﬁcantly more prominent in children with ASD, it appears that
there may be an overlap in social deﬁcits between subjects with ASD and ADHD
(Luteijn et al., 2000a, b). This all suggests that by subtyping families with (multi-
ple) ASD cases on ADHD characteristics and by subtyping families with (multi-
ple) ADHD cases on ASD characteristics, one can achieve more homogeneous
samples and obtain stronger signals in molecular-genetic studies and reﬁne areas
of the genome that are implicated in both disorders (Table 1). Similar considera-
tions apply to the subtyping of dyslexia samples for ADHD and of ADHD
samples for dyslexia (Loo et al., 2004).
A fourth factor is that of genetic heterogeneity, i.e. different sets of genes
may be responsible for risk in different families. This locus heterogeneity may
reduce power to detect linkage in traditional affected sibpair studies. On the
other hand, the QTLs associated with ADHD are expected to be common
genetic variants that are found across human populations (Wright et al.,
1999; Risch, 2000). Thus, if population heterogeneity does exist, it is expected
to lead to differing prevalence of QTLs in different groups, rather than presence
or absence. In ADHD, the prevalence of the DRD4 7-repeat allele, which has
been associated with ADHD, varies among populations (Chang et al., 1996).
We expect this will be true of other ADHD susceptibility alleles because they
ADHD: strategies to unravel its genetic architecture 9
are likely to be common alleles, which cause minor, additive deviations in
neurodevelopment or neurotransmission. In spite of this, genetic heterogeneity
points to the importance of genetic designs which are complementary to
affected sibpair designs, such as those using extended 3-generation pedigrees.
Fifth, a full understanding of the genetics of complex behavioral disorders
like ADHD will require insights into how environmental risks factors combine
with genes to inﬂuence the disorder and its clinical features. Some genes might
affect ADHD by inﬂuencing sensitivity to environmental risks (gene-environ-
ment interaction, GE) or modifying the probability of exposure to environ-
mental risks (gene-environment correlation, rGE). Some other environmental
risks may increase susceptibility to ADHD independent of genotype. The
potential role of GE effects contributing to complex behavioral disorders
has recently been demonstrated by two reports from the Dunedin Multidisci-
plinary Health and Development Study on antisocial behavior and depression
in which functional polymorphisms in candidate genes moderated the effects
known of environmental stressors, with MAOA moderating the inﬂuence of
parental maltreatment on antisocial behavior (Caspi et al., 2002) and the sero-
tonin transporter gene moderating the inﬂuence of stressful life events on
depression (Caspi et al., 2003). Neither of the two genes investigated showed
main effects with the behavioral phenotypes in the Dunedin dataset, illustrating
the important point that gene associations may be missed if environmental
measures are not taken into account. To date, few molecular genetic studies
of ADHD have incorporated environmental risk measures. Kahn et al. (2003)
found that in pre-school children, hyperactivity-impulsivity and oppositional
behavior were associated with the DAT1 10-repeat allele, but only when the
child was also exposed to maternal prenatal smoking. Another study explored
the possibility of an interaction between the DRD4 gene and season of birth
(Seeger et al., 2004). A seasonal pattern of birth has been proposed for different
subtypes of ADHD. Therefore, in a subgroup of children with ADHD and
conduct disorder, and in healthy controls, children carrying the 7-repeat allele
of DRD4 showed different relative risks for developing ADHD and comorbid
conduct disorder, depending on the season of birth. This suggests the very likely
hypothesis that ADHD, as a multifactorial disorder, may result from variations
in genes which have small main effects but whose effects are conditional upon
exposure to environmental risk and may be strongly ampliﬁed by these envi-
ronmental risks. If risk exposure differs among participants within a sample,
genes may account for little variation in the phenotype. Failure to take account
of environmental risk factors in previous genetic studies may be responsible for
part of the non-replication results. When exposure to environmental risks differs
signiﬁcantly between samples, candidate genes or regions may fail replication.
An additional strategy is to address heterogeneity at the level of endophe-
notypes. Endophenotypes are latent traits that are heritable, share genetic load-
ing with the disease phenotype, and are probabilistically related to the disease
phenotype as deﬁned in DSM-IV or ICD-10 (Gottesman et al., 2003; Skuse,
2001; Leboyer et al., 1998). These latent traits, which can be measured at a
physiological, neurobiological, or cognitive level, may be more closely linked
to the underlying genetic factors than the behavioral phenotype and that they
10 J. K. Buitelaar
mediate gene-clinical phenotype pathways (see Fig. 1). A smaller set of genes
may be involved in the endophenotypes than in the complex behavioral trait or
clinical disorder. Endophenotypes may improve the power of molecular genetic
studies and may also provide a means of parsing genetic heterogeneity. After
many years of searching for one single simple neuropsychological deﬁcit there
is a growing realization that ADHD is probably best conceptualized as a neu-
ropsychologically heterogenous condition with differentiable neuropsychologi-
cal pathways linking speciﬁc putative causes to the clinical phenotype (Sonuga-
Barke, 2003). These are some studies that suggest that familial ADHD may
represent a form of ADHD characterized by a deﬁcient response inhibition. In
a study that included ADHD probands with a family history of ADHD, their
nonaffected siblings, and normal controls matched for age and IQ, the non-
affected siblings were as impaired in measures of response inhibition as the
affected probands when compared to the normal controls (Slaats-Willemse et al.,
2003). Subjects with ADHD who had a family history of ADHD performed
signiﬁcantly worse on measures of response inhibition than subjects with
ADHD without such a family history (Seidman et al., 1995). In addition, chil-
dren who exhibited poor inhibition (on the stop signal task) were signiﬁcantly
more likely to have a ﬁrst-degree relative with ADHD than were the children
with ADHD who exhibited good behavioral inhibition (Crosbie et al., 2001).
The inﬂuence of increased familial risk for ADHD has also been studied
on measures of brain morphology (Durston et al., 2004). Both subjects with
ADHD and their unaffected siblings displayed reductions in right prefrontal gray
matter and left occipital gray and white matter of up to 9.1%. Right cerebellar
volume was reduced by 4.9% in subjects with ADHD but not in their unaffected
siblings. A 4.0% reduction in intracranial volume was found in subjects with
ADHD, while a trend was observed in their unaffected siblings. Thus, the volu-
metric reductions in cortical gray and white matter in subjects with ADHD were
also present in their unaffected siblings, suggesting that they are related to an
increased familial risk for the disorder. In contrast, the cerebellum is unaffected
in siblings, suggesting that the reduction in volume observed in subjects with
ADHD may be more directly related to the pathophysiology of this disorder
Fig. 1. Outline of the principle of the endophenotype. A smaller set of genes may be involved
in the endophenotype than in the complex behavioral trait of clinical disorder
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(Durston et al., 2004). A further study on the same date-set reported that the
DAT1 gene, a gene expressed predominantly in the basal ganglia, preferentially
inﬂuences caudate volume, whereas the DRD4 gene, a gene expressed predomi-
nantly in the prefrontal cortex, preferentially inﬂuences prefrontal gray matter
volume in a sample of subjects including subjects with ADHD, their unaffected
siblings, and healthy controls (Durston et al., 2005). This demonstrates that, by
constraining investigations by prior knowledge of gene expression and by using
endophenotypes, such as measures of brain morphology, we may begin to map
out the pathways by which genes inﬂuence behaviour.
Finally, genetic studies in ADHD have disregarded the importance of devel-
opmental factors. Different genes may be operating at different ages or develop-
mental stages. In a longitudinal twin study, the relatively high stability of ADHD
symptoms over a 5-year period between age 8=9 and age 13=14 year was found.
This continuity was mainly due to the same genetic effects operating at both
points in time. Change in symptoms between childhood and early adolescence
was to a large extent due to new genetic effects in early adolescence but also due
to new nonshared environmental effects that became important during adoles-
cence (Larsson et al., 2004). Rather similar results were obtained in another
longitudinal twin study which spanned ages 3, 7, 10, and 12 year and used ma-
ternal ratings of problem behaviors (Bartels et al., 2004). Stability in externaliz-
ing behaviors was accounted for by genetic and shared environmental inﬂuences.
The genetic contribution to stability for externalizing behaviors was 60% and
resulted from the fact that a subset of genes expressed at an earlier age was still
active at the next time point. In addition, signiﬁcant age-speciﬁc inﬂuences were
found for all components, indicating that genetic and environmental factors also
contributed to changes in problem behavior. Genetic studies in ADHD should be
enriched with a developmental perspective, and explore whether variables as age
of onset and severity of disease at various points in time (rather than persistence
per se) are relevant developmental endophenotypes.
Concluding remarks
Genetic research of complex disorders like ADHD is one of the most powerful
tools to increase our insight into the underlying pathophysiology of the disor-
der. In the absence of direct neural tissue such as obtained post-mortem or by
biopsy, no direct clues as to the neurochemical or cellular or molecular changes
at the level of the brain are available. The identiﬁcation of relevant genes opens
new avenues to approach the cellular and molecular base of the disorder. Ulti-
mately, this has the potential to individualize treatment, to facilitate prevention,
and to develop new and effective treatments.
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